KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $882,650 | -2.0% | 5,220 | +25.7% | 0.00% | 0.0% |
| Q2 2023 | $900,578 | +38.8% | 4,153 | +16.3% | 0.00% | +33.3% |
| Q1 2023 | $648,818 | +0.3% | 3,572 | +8.5% | 0.00% | 0.0% |
| Q4 2022 | $646,682 | -20.7% | 3,291 | -9.2% | 0.00% | -40.0% |
| Q3 2022 | $815,000 | +573.6% | 3,624 | +277.5% | 0.01% | +400.0% |
| Q2 2022 | $121,000 | -2.4% | 960 | -1.7% | 0.00% | 0.0% |
| Q1 2022 | $124,000 | +27.8% | 977 | +32.0% | 0.00% | – |
| Q4 2021 | $97,000 | +155.3% | 740 | +137.9% | 0.00% | – |
| Q3 2021 | $38,000 | +8.6% | 311 | 0.0% | 0.00% | – |
| Q2 2021 | $35,000 | -5.4% | 311 | 0.0% | 0.00% | – |
| Q1 2021 | $37,000 | +15.6% | 311 | 0.0% | 0.00% | – |
| Q4 2020 | $32,000 | +33.3% | 311 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | – | 311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
| Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
| Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
| Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
| Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
| Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
| DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
| Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
| CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
| Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |